Jazz Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Jazz Pharmaceuticals (Nasdaq: JAZZ) has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. Chairman and CEO Bruce Cozadd will deliver a corporate presentation and business update on January 14, 2025, at 9:45 a.m. PST.
The presentation will be accessible via webcast through the Investors section of Jazz Pharmaceuticals' website, with a replay available for 30 days post-conference. Jazz Pharmaceuticals is a global biopharma company focused on developing life-changing medicines for serious diseases, particularly in sleep disorders, epilepsy, and cancer treatments. The company maintains its headquarters in Dublin, Ireland, with research, development, and manufacturing facilities across multiple countries.
Jazz Pharmaceuticals (Nasdaq: JAZZ) ha annunciato la sua partecipazione alla 43ª Conferenza Sanitaria Annuale J.P. Morgan. Il presidente e CEO Bruce Cozadd presenterà un intervento aziendale e un aggiornamento il 14 gennaio 2025, alle 9:45 PST.
La presentazione sarà accessibile tramite webcast nella sezione Investitori del sito web di Jazz Pharmaceuticals, con una registrazione disponibile per 30 giorni dopo la conferenza. Jazz Pharmaceuticals è un'azienda biopharma globale che si concentra sullo sviluppo di farmaci che possono cambiare la vita per malattie gravi, in particolare nei disturbi del sonno, nell'epilessia e nei trattamenti per il cancro. L'azienda ha sede a Dublino, Irlanda, e dispone di strutture di ricerca, sviluppo e produzione in vari paesi.
Jazz Pharmaceuticals (Nasdaq: JAZZ) ha anunciado su participación en la 43ª Conferencia Anual de Salud J.P. Morgan. El presidente y CEO Bruce Cozadd presentará una conferencia corporativa y una actualización comercial el 14 de enero de 2025, a las 9:45 a.m. PST.
La presentación estará disponible a través de un webcast en la sección de Inversores del sitio web de Jazz Pharmaceuticals, con una grabación disponible durante 30 días después de la conferencia. Jazz Pharmaceuticals es una empresa biopharma global dedicada al desarrollo de medicamentos que cambian vidas para enfermedades graves, en particular en trastornos del sueño, epilepsia y tratamientos contra el cáncer. La empresa tiene su sede en Dublín, Irlanda, y cuenta con instalaciones de investigación, desarrollo y fabricación en varios países.
재즈 제약 (나스닥: JAZZ)는 제43회 연례 J.P. 모건 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 회장 겸 CEO인 브루스 코자드는 2025년 1월 14일 오전 9시 45분 PST에 기업 발표 및 사업 업데이트를 진행할 예정입니다.
이번 발표는 재즈 제약 웹사이트의 투자자 섹션을 통해 웹캐스트로 접근할 수 있으며, 컨퍼런스 종료 후 30일 동안 다시 볼 수 있습니다. 재즈 제약은 심각한 질병을 위한 삶을 변화시키는 약물을 개발하는 데 주력하는 글로벌 바이오제약 회사입니다. 주로 수면장애, 간질 및 암 치료에 집중하고 있습니다. 회사는 아일랜드 더블린에 본사를 두고 있으며, 여러 국가에 연구, 개발 및 제조 시설을 운영하고 있습니다.
Jazz Pharmaceuticals (Nasdaq : JAZZ) a annoncé sa participation à la 43e Conférence Annuelle J.P. Morgan sur la Santé. Le président et CEO Bruce Cozadd présentera une présentation d'entreprise et une mise à jour commerciale le 14 janvier 2025 à 9h45 PST.
La présentation sera accessible par webcast dans la section Investisseurs du site de Jazz Pharmaceuticals, avec une rediffusion disponible pendant 30 jours après la conférence. Jazz Pharmaceuticals est une entreprise biopharmaceutique mondiale axée sur le développement de médicaments transformant la vie pour des maladies graves, en particulier dans les troubles du sommeil, l'épilepsie et les traitements du cancer. L'entreprise a son siège à Dublin, en Irlande, et dispose d'installations de recherche, de développement et de fabrication dans plusieurs pays.
Jazz Pharmaceuticals (Nasdaq: JAZZ) hat seine Teilnahme an der 43. jährlichen J.P. Morgan Healthcare Conference angekündigt. Der Vorsitzende und CEO Bruce Cozadd wird am 14. Januar 2025 um 9:45 Uhr PST eine Unternehmenspräsentation und Geschäftaktualisierung halten.
Die Präsentation wird über einen Webcast im Investorenbereich der Website von Jazz Pharmaceuticals verfügbar sein, mit einer Aufzeichnung, die 30 Tage nach der Konferenz zur Verfügung steht. Jazz Pharmaceuticals ist ein globales Biopharmaunternehmen, das sich auf die Entwicklung lebensverändernder Medikamente für schwere Krankheiten konzentriert, insbesondere bei Schlafstörungen, Epilepsie und Krebsbehandlungen. Das Unternehmen hat seinen Hauptsitz in Dublin, Irland, und verfügt über Forschungs-, Entwicklungs- und Produktionsstätten in mehreren Ländern.
- None.
- None.
A live audio webcast of the presentation may be accessed via the Investors section of the Jazz Pharmaceuticals website at https://investor.jazzpharma.com/investors/events-presentations. A replay of the webcast will be available on the website for 30 days following the conference.
About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharma company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing potentially life-changing medicines for people with serious diseases — often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines, including leading therapies for sleep disorders and epilepsy, and a growing portfolio of cancer treatments. Our patient-focused and science-driven approach powers pioneering research and development advancements across our robust pipeline of innovative therapeutics in oncology and neuroscience. Jazz is headquartered in
Contacts:
Investors:
Jeff Macdonald
Executive Director, Investor Relations
Jazz Pharmaceuticals plc
InvestorInfo@jazzpharma.com
Media:
Kristin Bhavnani
Head of Global Corporate Communications
Jazz Pharmaceuticals plc
CorporateAffairsMediaInfo@jazzpharma.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-to-present-at-the-43rd-annual-jp-morgan-healthcare-conference-302334228.html
SOURCE Jazz Pharmaceuticals plc
FAQ
When is Jazz Pharmaceuticals (JAZZ) presenting at the J.P. Morgan Healthcare Conference 2025?
How can investors access JAZZ's J.P. Morgan Healthcare Conference presentation?
What are the main therapeutic areas for Jazz Pharmaceuticals (JAZZ)?
Where is Jazz Pharmaceuticals (JAZZ) headquartered?
Who will be presenting for Jazz Pharmaceuticals (JAZZ) at the J.P. Morgan Healthcare Conference?
